Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Books | 1 | 2018 | 22 | 0.72 | Why? |
| Writing | 1 | 2018 | 123 | 0.63 | Why? |
| Microcephaly | 1 | 2018 | 181 | 0.61 | Why? |
| Social Networking | 2 | 2020 | 737 | 0.58 | Why? |
| Ships | 2 | 2020 | 1046 | 0.57 | Why? |
| Social Behavior | 5 | 2018 | 882 | 0.48 | Why? |
| Abortion, Spontaneous | 1 | 2018 | 776 | 0.46 | Why? |
| Models, Theoretical | 10 | 2021 | 6659 | 0.46 | Why? |
| Epidemics | 8 | 2020 | 6407 | 0.45 | Why? |
| Measles | 1 | 2019 | 608 | 0.45 | Why? |
| Science | 1 | 2018 | 463 | 0.43 | Why? |
| Disease Outbreaks | 6 | 2020 | 27595 | 0.38 | Why? |
| Polymerase Chain Reaction | 2 | 2021 | 6740 | 0.37 | Why? |
| Contact Tracing | 8 | 2021 | 8448 | 0.37 | Why? |
| Travel | 5 | 2021 | 7220 | 0.36 | Why? |
| Zika Virus Infection | 3 | 2019 | 1920 | 0.35 | Why? |
| Risk | 1 | 2020 | 5288 | 0.34 | Why? |
| Ebola Vaccines | 2 | 2017 | 126 | 0.30 | Why? |
| Hemorrhagic Fever, Ebola | 4 | 2017 | 1475 | 0.30 | Why? |
| Dengue | 1 | 2018 | 1565 | 0.30 | Why? |
| Epidemiological Monitoring | 1 | 2018 | 3493 | 0.29 | Why? |
| Influenza A virus | 1 | 2017 | 2234 | 0.29 | Why? |
| Coronavirus Infections | 16 | 2020 | 253789 | 0.27 | Why? |
| Serologic Tests | 1 | 2018 | 4359 | 0.27 | Why? |
| Schools | 1 | 2018 | 4187 | 0.24 | Why? |
| Patient Isolation | 3 | 2020 | 3182 | 0.24 | Why? |
| Fiji | 2 | 2018 | 31 | 0.24 | Why? |
| Pneumonia, Viral | 14 | 2020 | 243684 | 0.22 | Why? |
| Coronavirus | 3 | 2020 | 18339 | 0.21 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.20 | Why? |
| Biological Science Disciplines | 1 | 2020 | 72 | 0.20 | Why? |
| Communicable Disease Control | 6 | 2021 | 29620 | 0.20 | Why? |
| Reward | 1 | 2020 | 146 | 0.19 | Why? |
| Health | 1 | 2020 | 130 | 0.19 | Why? |
| Web Browser | 1 | 2019 | 84 | 0.19 | Why? |
| Disease Transmission, Infectious | 2 | 2018 | 9044 | 0.17 | Why? |
| Decision Trees | 1 | 2019 | 441 | 0.17 | Why? |
| Salmonella Infections | 1 | 2017 | 82 | 0.16 | Why? |
| Bayes Theorem | 3 | 2021 | 3237 | 0.16 | Why? |
| Measles Vaccine | 1 | 2019 | 301 | 0.15 | Why? |
| Betacoronavirus | 11 | 2020 | 204454 | 0.15 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2020 | 12361 | 0.15 | Why? |
| Access to Information | 1 | 2020 | 483 | 0.15 | Why? |
| Eating | 1 | 2017 | 395 | 0.14 | Why? |
| Basic Reproduction Number | 3 | 2021 | 2676 | 0.14 | Why? |
| Immunity, Herd | 2 | 2021 | 1011 | 0.14 | Why? |
| Humans | 38 | 2021 | 930598 | 0.13 | Why? |
| Pandemics | 13 | 2021 | 389249 | 0.12 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.12 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.12 | Why? |
| Clinical Trials, Phase III as Topic | 1 | 2016 | 782 | 0.12 | Why? |
| Influenza, Human | 1 | 2017 | 10779 | 0.12 | Why? |
| Communicable Diseases, Imported | 1 | 2020 | 843 | 0.12 | Why? |
| United Kingdom | 4 | 2021 | 18046 | 0.12 | Why? |
| Family Characteristics | 2 | 2020 | 2551 | 0.12 | Why? |
| Pneumococcal Infections | 1 | 2018 | 562 | 0.11 | Why? |
| Biological Evolution | 1 | 2017 | 641 | 0.11 | Why? |
| Child | 9 | 2021 | 70012 | 0.11 | Why? |
| Publishing | 1 | 2020 | 990 | 0.10 | Why? |
| Quarantine | 4 | 2021 | 18418 | 0.10 | Why? |
| Mass Screening | 2 | 2020 | 8005 | 0.10 | Why? |
| Adolescent | 8 | 2021 | 86841 | 0.10 | Why? |
| Software | 1 | 2020 | 2501 | 0.09 | Why? |
| Models, Statistical | 4 | 2020 | 5312 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.09 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.09 | Why? |
| Cluster Analysis | 1 | 2015 | 3001 | 0.08 | Why? |
| Point-of-Care Systems | 1 | 2020 | 2955 | 0.08 | Why? |
| Self Report | 1 | 2018 | 3802 | 0.08 | Why? |
| Europe | 2 | 2021 | 12702 | 0.08 | Why? |
| Antibodies, Viral | 1 | 2018 | 51949 | 0.07 | Why? |
| Seasons | 1 | 2018 | 4071 | 0.07 | Why? |
| Incidence | 4 | 2020 | 25622 | 0.07 | Why? |
| International Cooperation | 1 | 2019 | 3436 | 0.07 | Why? |
| Child, Preschool | 5 | 2021 | 36283 | 0.07 | Why? |
| Universities | 1 | 2020 | 4374 | 0.07 | Why? |
| Young Adult | 7 | 2021 | 93724 | 0.07 | Why? |
| Mobile Applications | 1 | 2021 | 3032 | 0.07 | Why? |
| Pregnancy Outcome | 1 | 2018 | 3803 | 0.07 | Why? |
| Female | 10 | 2021 | 380317 | 0.07 | Why? |
| Uganda | 2 | 2018 | 1057 | 0.07 | Why? |
| Brazil | 2 | 2021 | 12582 | 0.07 | Why? |
| Models, Biological | 1 | 2020 | 4907 | 0.06 | Why? |
| Communicable Diseases | 1 | 2018 | 2148 | 0.06 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.06 | Why? |
| Research Design | 1 | 2019 | 5830 | 0.06 | Why? |
| Male | 9 | 2021 | 367725 | 0.06 | Why? |
| Republic of Korea | 1 | 2015 | 5858 | 0.06 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.06 | Why? |
| Niger | 1 | 2020 | 116 | 0.05 | Why? |
| Influenza Vaccines | 1 | 2017 | 2941 | 0.05 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.05 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.05 | Why? |
| Infant | 2 | 2021 | 30274 | 0.05 | Why? |
| Vaccines | 1 | 2019 | 3692 | 0.05 | Why? |
| Communication | 1 | 2018 | 5206 | 0.05 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2019 | 7330 | 0.05 | Why? |
| Calibration | 1 | 2020 | 307 | 0.05 | Why? |
| Evaluation Studies as Topic | 1 | 2021 | 391 | 0.05 | Why? |
| Human Activities | 1 | 2021 | 293 | 0.05 | Why? |
| Proof of Concept Study | 1 | 2021 | 696 | 0.05 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.05 | Why? |
| Patient Acceptance of Health Care | 1 | 2017 | 5002 | 0.04 | Why? |
| Adult | 7 | 2021 | 244371 | 0.04 | Why? |
| Pacific Islands | 1 | 2017 | 152 | 0.04 | Why? |
| Liberia | 1 | 2017 | 108 | 0.04 | Why? |
| Guinea | 1 | 2017 | 228 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.04 | Why? |
| Sierra Leone | 1 | 2016 | 267 | 0.04 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.04 | Why? |
| China | 2 | 2020 | 50654 | 0.04 | Why? |
| Zika Virus | 2 | 2019 | 1924 | 0.04 | Why? |
| Ownership | 1 | 2017 | 169 | 0.04 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.04 | Why? |
| Animals, Domestic | 1 | 2017 | 272 | 0.04 | Why? |
| Aged | 4 | 2021 | 215776 | 0.04 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.04 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.04 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.04 | Why? |
| Time | 1 | 2016 | 631 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2015 | 8843 | 0.03 | Why? |
| Nigeria | 1 | 2020 | 2292 | 0.03 | Why? |
| Sexual Partners | 1 | 2018 | 612 | 0.03 | Why? |
| Latin America | 1 | 2018 | 1721 | 0.03 | Why? |
| Socioeconomic Factors | 2 | 2021 | 8495 | 0.03 | Why? |
| Program Evaluation | 1 | 2020 | 1929 | 0.03 | Why? |
| Singapore | 1 | 2021 | 3641 | 0.03 | Why? |
| Public Health | 1 | 2017 | 16359 | 0.03 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.03 | Why? |
| Disease Eradication | 1 | 2017 | 581 | 0.03 | Why? |
| Feasibility Studies | 1 | 2020 | 3467 | 0.03 | Why? |
| Cost of Illness | 1 | 2020 | 1903 | 0.02 | Why? |
| Uncertainty | 1 | 2020 | 1888 | 0.02 | Why? |
| England | 1 | 2021 | 5116 | 0.02 | Why? |
| Sexual Behavior | 1 | 2018 | 1322 | 0.02 | Why? |
| Carrier State | 1 | 2018 | 2100 | 0.02 | Why? |
| Computational Biology | 1 | 2021 | 4514 | 0.02 | Why? |
| Rural Population | 1 | 2018 | 2408 | 0.02 | Why? |
| World Health Organization | 1 | 2018 | 4213 | 0.02 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.02 | Why? |
| Algorithms | 1 | 2021 | 7346 | 0.02 | Why? |
| Forecasting | 1 | 2016 | 4492 | 0.01 | Why? |
| Infection Control | 2 | 2021 | 23131 | 0.01 | Why? |
| Health Policy | 1 | 2021 | 6242 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2018 | 43792 | 0.01 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2016 | 11304 | 0.01 | Why? |
| Social Media | 1 | 2021 | 5798 | 0.01 | Why? |
| Occupational Exposure | 1 | 2017 | 4742 | 0.01 | Why? |
| Animals | 2 | 2018 | 78931 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| United States | 1 | 2021 | 46150 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Health Personnel | 1 | 2017 | 29646 | 0.01 | Why? |
Kucharski's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(161)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(131)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_